Starting on:
Nov 6, 2024
Ending on:
Nov 6, 2024
Moderator(s):
AIC Litein Hospital
Max Credits:
3 Points
Provider:
AIC LITEIN MISSION HOSPITAL
Claim Points
Nov 6, 2024
Ending on:
Nov 6, 2024
Moderator(s):
Dr.
Deborah Jakait
CME coordinator
Mr. Kibet Eliug
Bureti subcounty TB manager
Venue: CME coordinator
Mr. Kibet Eliug
Bureti subcounty TB manager
AIC Litein Hospital
Max Credits:
3 Points
Provider:
AIC LITEIN MISSION HOSPITAL
Claim Points
Updates on MDR/RR TB management
Starting on:
Nov 6, 2024
Nov 6, 2024
Ending on:
Nov 6, 2024
Nov 6, 2024
Venue:
AIC Litein Hospital
AIC Litein Hospital
Description
A Continuing Medical Education (CME) session on updates in managing Multi-Drug Resistant (MDR) and Rifampicin-Resistant (RR) Tuberculosis (TB) would provide healthcare providers with the latest advancements, guidelines, and strategies for diagnosing and treating these challenging forms of TB. This session would cover recent developments in pharmacological treatments, diagnostic tools, and patient care approaches to improve outcomes and reduce transmission
Objectives
To understand the latest WHO guidelines , Kenya guidlinesand treatment protocols for managing MDR and RR TB, including new and repurposed drugs.
To review advancements in diagnostic methods and monitoring for MDR/RR TB, focusing on rapid testing and patient follow-up.
To explore strategies for addressing treatment adherence challenges and reducing transmission within communities, particularly in high-risk populations.